CD4+ T Cells Recognizing PE/PPE Antigens Directly or via Cross Reactivity Are Protective against Pulmonary Mycobacterium tuberculosis Infection

Mycobacterium tuberculosis (Mtb), possesses at least three type VII secretion systems, ESX-1, -3 and -5 that are actively involved in pathogenesis and host-pathogen interaction. We recently showed that an attenuated Mtb vaccine candidate (Mtb Δppe25-pe19), which lacks the characteristic ESX-5-associated pe/ppe genes, but harbors all other components of the ESX-5 system, induces CD4+ T-cell immune responses against non-esx-5-associated PE/PPE protein homologs. These T cells strongly cross-recognize the missing esx-5-associated PE/PPE proteins. Here, we characterized the fine composition of the functional cross-reactive Th1 effector subsets specific to the shared PE/PPE epitopes in mice immunized with the Mtb Δppe25-pe19 vaccine candidate. We provide evidence that the Mtb Δppe25-pe19 strain, despite its significant attenuation, is comparable to the WT Mtb strain with regard to: (i) its antigenic repertoire related to the different ESX systems, (ii) the induced Th1 effector subset composition, (iii) the differentiation status of the Th1 cells induced, and (iv) its particular features at stimulating the innate immune response. Indeed, we found significant contribution of PE/PPE-specific Th1 effector cells in the protective immunity against pulmonary Mtb infection. These results offer detailed insights into the immune mechanisms underlying the remarkable protective efficacy of the live attenuated Mtb Δppe25-pe19 vaccine candidate, as well as the specific potential of PE/PPE proteins as protective immunogens.

[1]  S. Kaufmann,et al.  ESAT-6-dependent cytosolic pattern recognition drives noncognate tuberculosis control in vivo. , 2016, The Journal of clinical investigation.

[2]  A. Sharpe,et al.  CD4 T Cell-Derived IFN-γ Plays a Minimal Role in Control of Pulmonary Mycobacterium tuberculosis Infection and Must Be Actively Repressed by PD-1 to Prevent Lethal Disease , 2016, PLoS pathogens.

[3]  R. Brosch,et al.  The BCG Strain Pool: Diversity Matters. , 2016, Molecular therapy : the journal of the American Society of Gene Therapy.

[4]  Mathias Vandenbogaert,et al.  Mycobacterial Pan-Genome Analysis Suggests Important Role of Plasmids in the Radiation of Type VII Secretion Systems , 2016, Genome biology and evolution.

[5]  Chun-yan Jin,et al.  Variable Virulence and Efficacy of BCG Vaccine Strains in Mice and Correlation With Genome Polymorphisms , 2015, Molecular therapy : the journal of the American Society of Gene Therapy.

[6]  Jonathan L. Schmid-Burgk,et al.  Mycobacterium tuberculosis Differentially Activates cGAS- and Inflammasome-Dependent Intracellular Immune Responses through ESX-1. , 2015, Cell host & microbe.

[7]  H. Virgin,et al.  The Cytosolic Sensor cGAS Detects Mycobacterium tuberculosis DNA to Induce Type I Interferons and Activate Autophagy. , 2015, Cell host & microbe.

[8]  R. Brosch,et al.  Mycobacterium tuberculosis Meets the Cytosol: The Role of cGAS in Anti-mycobacterial Immunity. , 2015, Cell host & microbe.

[9]  Zhijian J. Chen,et al.  Cyclic GMP-AMP Synthase Is an Innate Immune DNA Sensor for Mycobacterium tuberculosis. , 2015, Cell host & microbe.

[10]  H. Mollenkopf,et al.  The Recombinant BCG ΔureC::hly Vaccine Targets the AIM2 Inflammasome to Induce Autophagy and Inflammation. , 2015, The Journal of infectious diseases.

[11]  R. Warren,et al.  Phylogeny to function: PE/PPE protein evolution and impact on Mycobacterium tuberculosis pathogenicity , 2015, Molecular microbiology.

[12]  R. Brosch,et al.  Increased protective efficacy of recombinant BCG strains expressing virulence-neutral proteins of the ESX-1 secretion system. , 2015, Vaccine.

[13]  T. Scriba,et al.  T cells and adaptive immunity to Mycobacterium tuberculosis in humans , 2015, Immunological reviews.

[14]  A. Casadevall,et al.  Release of mycobacterial antigens , 2015, Immunological reviews.

[15]  I. Orme,et al.  The onset of adaptive immunity in the mouse model of tuberculosis and the factors that compromise its expression , 2015, Immunological reviews.

[16]  R. Brosch,et al.  Cytosolic Access of Mycobacterium tuberculosis: Critical Impact of Phagosomal Acidification Control and Demonstration of Occurrence In Vivo , 2015, PLoS pathogens.

[17]  D. Barber,et al.  Cutting Edge: Control of Mycobacterium tuberculosis Infection by a Subset of Lung Parenchyma–Homing CD4 T Cells , 2014, The Journal of Immunology.

[18]  R. Copin,et al.  Sequence Diversity in the pe_pgrs Genes of Mycobacterium tuberculosis Is Independent of Human T Cell Recognition , 2014, mBio.

[19]  S. Sridhar,et al.  Harnessing local and systemic immunity for vaccines against tuberculosis , 2013, Mucosal Immunology.

[20]  C. Leclerc,et al.  Induction of protective immunity against Mycobacterium tuberculosis by delivery of ESX antigens into airway dendritic cells , 2012, Mucosal Immunology.

[21]  Bjoern Peters,et al.  Memory T Cells in Latent Mycobacterium tuberculosis Infection Are Directed against Three Antigenic Islands and Largely Contained in a CXCR3+CCR6+ Th1 Subset , 2013, PLoS pathogens.

[22]  R. Wilkinson,et al.  Conserved Immune Recognition Hierarchy of Mycobacterial PE/PPE Proteins during Infection in Natural Hosts , 2012, PloS one.

[23]  R. Brosch,et al.  Strong immunogenicity and cross-reactivity of Mycobacterium tuberculosis ESX-5 type VII secretion: encoded PE-PPE proteins predicts vaccine potential. , 2012, Cell host & microbe.

[24]  R. Brosch,et al.  Disruption of the ESX‐5 system of Mycobacterium tuberculosis causes loss of PPE protein secretion, reduction of cell wall integrity and strong attenuation , 2012, Molecular microbiology.

[25]  G. Fadda,et al.  PE_PGRS30 is required for the full virulence of Mycobacterium tuberculosis , 2012, Cellular microbiology.

[26]  P. Cardona.  Understanding Tuberculosis - Analyzing the Origin of Mycobacterium Tuberculosis Pathogenicity , 2012 .

[27]  F. Dieli,et al.  Are Polyfunctional Cells Protective in M. tuberculosis Infection , 2012 .

[28]  R. Brosch,et al.  Phagosomal Rupture by Mycobacterium tuberculosis Results in Toxicity and Host Cell Death , 2012, PLoS pathogens.

[29]  D. Sherman,et al.  The multistage vaccine H56 boosts the effects of BCG to protect cynomolgus macaques against active tuberculosis and reactivation of latent Mycobacterium tuberculosis infection. , 2012, The Journal of clinical investigation.

[30]  G. D. de Souza,et al.  Bacterial proteins with cleaved or uncleaved signal peptides of the general secretory pathway. , 2011, Journal of proteomics.

[31]  T. Ottenhoff,et al.  Mycobacterial Secretion Systems ESX-1 and ESX-5 Play Distinct Roles in Host Cell Death and Inflammasome Activation , 2011, The Journal of Immunology.

[32]  Q. Gao,et al.  PPE38 Modulates the Innate Immune Response and Is Required for Mycobacterium marinum Virulence , 2011, Infection and Immunity.

[33]  J. Drijfhout,et al.  Double‐ and monofunctional CD4+ and CD8+ T‐cell responses to Mycobacterium tuberculosis DosR antigens and peptides in long‐term latently infected individuals , 2011, European journal of immunology.

[34]  Bing Chen,et al.  A recombinant Mycobacterium smegmatis induces potent bactericidal immunity against Mycobacterium tuberculosis , 2011, Nature Medicine.

[35]  A. Sher,et al.  Role of innate cytokines in mycobacterial infection , 2011, Mucosal Immunology.

[36]  S. Fortune,et al.  Rv3615c is a highly immunodominant RD1 (Region of Difference 1)-dependent secreted antigen specific for Mycobacterium tuberculosis infection , 2011, Proceedings of the National Academy of Sciences.

[37]  G. Pantaleo,et al.  Dominant TNF-α+ Mycobacterium tuberculosis–specific CD4+ T cell responses discriminate between latent infection and active disease , 2011, Nature Medicine.

[38]  G. Schoolnik,et al.  A multistage tuberculosis vaccine that confers efficient protection before and after exposure , 2011, Nature Medicine.

[39]  S. Sampson,et al.  Mycobacterial PE/PPE Proteins at the Host-Pathogen Interface , 2011, Clinical & developmental immunology.

[40]  G. Kaplan,et al.  Specific T cell frequency and cytokine expression profile do not correlate with protection against tuberculosis after bacillus Calmette-Guérin vaccination of newborns. , 2010, American journal of respiratory and critical care medicine.

[41]  A. Genovesio,et al.  High Content Phenotypic Cell-Based Visual Screen Identifies Mycobacterium tuberculosis Acyltrehalose-Containing Glycolipids Involved in Phagosome Remodeling , 2010, PLoS pathogens.

[42]  M. Brennan,et al.  The second Geneva Consensus: Recommendations for novel live TB vaccines. , 2010, Vaccine.

[43]  B. Bloom,et al.  The Transcriptional Regulator Rv0485 Modulates the Expression of a pe and ppe Gene Pair and Is Required for Mycobacterium tuberculosis Virulence , 2009, Infection and Immunity.

[44]  R. Brosch,et al.  Mycobacterial PE, PPE and ESX clusters: novel insights into the secretion of these most unusual protein families , 2009, Molecular microbiology.

[45]  M. Brennan,et al.  PPE and PE_PGRS proteins of Mycobacterium marinum are transported via the type VII secretion system ESX‐5 , 2009, Molecular microbiology.

[46]  P. Andersen,et al.  Tuberculosis Subunit Vaccination Provides Long-Term Protective Immunity Characterized by Multifunctional CD4 Memory T Cells1 , 2009, The Journal of Immunology.

[47]  R. Adegbola,et al.  Pattern and diversity of cytokine production differentiates between Mycobacterium tuberculosis infection and disease , 2009, European journal of immunology.

[48]  R. Brosch,et al.  ESX/type VII secretion systems and their role in host-pathogen interaction. , 2009, Current opinion in microbiology.

[49]  E. Alnemri,et al.  AIM2 activates the inflammasome and cell death in response to cytoplasmic DNA , 2009, Nature.

[50]  Daniel R. Caffrey,et al.  AIM2 recognizes cytosolic dsDNA and forms a caspase-1 activating inflammasome with ASC , 2009, Nature.

[51]  A. Hill,et al.  Multifunctional, High-Level Cytokine-Producing Th1 Cells in the Lung, but Not Spleen, Correlate with Protection against Mycobacterium tuberculosis Aerosol Challenge in Mice , 2008, The Journal of Immunology.

[52]  M S Shaila,et al.  Characterization of T-cell immunogenicity of two PE/PPE proteins of Mycobacterium tuberculosis. , 2008, Journal of medical microbiology.

[53]  M. Shaila,et al.  Detection of interferon gamma-secreting CD8+ T lymphocytes in humans specific for three PE/PPE proteins of Mycobacterium tuberculosis. , 2008, Microbes and infection.

[54]  Wilbert Bitter,et al.  Type VII secretion — mycobacteria show the way , 2007, Nature Reviews Microbiology.

[55]  A. Pawłowski,et al.  Should a new tuberculosis vaccine be administered intranasally? , 2007, Tuberculosis.

[56]  M S Shaila,et al.  Evaluation of T-cell responses to peptides with MHC class I-binding motifs derived from PE_PGRS 33 protein of Mycobacterium tuberculosis. , 2007, Journal of medical microbiology.

[57]  Paul D van Helden,et al.  Evolution and expansion of the Mycobacterium tuberculosis PE and PPE multigene families and their association with the duplication of the ESAT-6 (esx) gene cluster regions , 2006, BMC Evolutionary Biology.

[58]  David Eisenberg,et al.  A specific secretion system mediates PPE41 transport in pathogenic mycobacteria , 2006, Molecular microbiology.

[59]  R. Rappuoli,et al.  Mucosal Administration of Ag85B-ESAT-6 Protects against Infection with Mycobacterium tuberculosis and Boosts Prior Bacillus Calmette-Guérin Immunity1 , 2006, The Journal of Immunology.

[60]  E. Agger,et al.  Protective immunity to tuberculosis with Ag85B-ESAT-6 in a synthetic cationic adjuvant system IC31. , 2006, Vaccine.

[61]  S. Cole,et al.  Influence of ESAT-6 Secretion System 1 (RD1) of Mycobacterium tuberculosis on the Interaction between Mycobacteria and the Host Immune System1 , 2005, The Journal of Immunology.

[62]  Martin Wu,et al.  A Mycobacterium avium PPE gene is associated with the ability of the bacterium to grow in macrophages and virulence in mice , 2004, Cellular microbiology.

[63]  Priscille Brodin,et al.  ESAT-6 proteins: protective antigens and virulence factors? , 2004, Trends in microbiology.

[64]  A. Apt,et al.  CD4 T cells producing IFN‐γ in the lungs of mice challenged with mycobacteria express a CD27‐negative phenotype , 2004, Clinical and experimental immunology.

[65]  Ann Williams,et al.  Protective Effect of a Tuberculosis Subunit Vaccine Based on a Fusion of Antigen 85B and ESAT-6 in the Aerosol Guinea Pig Model , 2004, Infection and Immunity.

[66]  G. Schoolnik,et al.  Regulation of the Mycobacterium tuberculosis PE/PPE genes. , 2004, Tuberculosis.

[67]  S. Hasnain,et al.  PPE Antigen Rv2430c of Mycobacterium tuberculosis Induces a Strong B-Cell Response , 2003, Infection and Immunity.

[68]  S. Cole,et al.  Recombinant BCG exporting ESAT-6 confers enhanced protection against tuberculosis , 2003, Nature Medicine.

[69]  Priscille Brodin,et al.  Loss of RD1 contributed to the attenuation of the live tuberculosis vaccines Mycobacterium bovis BCG and Mycobacterium microti , 2002, Molecular microbiology.

[70]  M. Brennan,et al.  The PE multigene family: a 'molecular mantra' for mycobacteria. , 2002, Trends in microbiology.

[71]  William R. Jacobs,et al.  Evidence that Mycobacterial PE_PGRS Proteins Are Cell Surface Constituents That Influence Interactions with Other Cells , 2001, Infection and Immunity.

[72]  R M Warren,et al.  Expression, characterization and subcellular localization of the Mycobacterium tuberculosis PPE gene Rv1917c. , 2001, Tuberculosis.

[73]  M. Brennan,et al.  Comparative Immune Response to PE and PE_PGRS Antigens of Mycobacterium tuberculosis , 2001, Infection and Immunity.